Yahoo
NYSEArca - Delayed Quote USD

State Street SPDR S&P Homebuilders ETF (XHB)

103.25 +0.98 (+0.96%)
At close: September 4 at 4:00:00 PM EDT
102.36 -0.89 (-0.86%)
After hours: September 4 at 7:45:41 PM EDT
Trade XHB on Coinbase
Chart Range Bar
Loading chart for XHB
  • Previous Close 102.27
  • Open 101.84
  • Bid 101.74 x 30000
  • Ask 103.97 x 20000
  • Day's Range 101.77 - 103.53
  • 52 Week Range 93.57 - 123.13
  • Volume 1,536,966
  • Avg. Volume 2,408,387
  • Net Assets 1.33B
  • NAV 102.29
  • PE Ratio (TTM) 19.60
  • Yield 0.77%
  • YTD Daily Total Return -0.23%
  • Beta (5Y Monthly) 1.46
  • Expense Ratio (net) 0.35%

In seeking to track the performance of the S&P Homebuilders Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the homebuilders segment of the S&P Total Market Index ("S&P TMI").

State Street Investment Management

Fund Family

Consumer Cyclical

Fund Category

1.33B

Net Assets

2006-01-31

Inception Date

Performance Overview

View More

Trailing returns as of 9/3/2026. Category is Consumer Cyclical.

YTD Return

XHB
0.23%
Category
1.29%

1-Year Return

XHB
9.31%
Category
14.89%

3-Year Return

XHB
7.47%
Category
13.04%

People Also Watch

Holdings

View More

Top 10 Holdings (39.56% of Total Assets)

Symbol Company % Assets
IBP 4.42%
OC 4.27%
ALLE 4.27%
SKY 4.05%
WSM 3.93%
PHM 3.79%
CSL 3.76%
WMS 3.73%
TOL 3.68%
HD 3.66%

Sector Weightings

Research Reports

View More
  • Biogen Is Repositioning Its Portfolio To Partly Offset Ongoing Revenue Declines

    Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).

    Rating
    Price Target
  • AI momentum continuing

    Broadcom Inc. is a top five global fabless semiconductor company with leading franchises in wired and wireless communications, enterprise data center and storage, and other end markets. The former Avago acquired Broadcom for $37 billion in 2016 and changed its name to Broadcom Inc. The company has grown via hardware acquisitions, including Agere, LSI Logic, Brocade, and Emulex; and software acquisitions, including CA Inc. in November 2018 and Symantec's enterprise security business in November 2019. Broadcom completed the acquisition of VMware in December 2023.

    Rating
    Price Target
  • Broadcom Earnings: Bullish 2028 Outlook

    Broadcom is one of the largest semiconductor companies in the world and has also expanded into infrastructure software. Its semiconductors primarily serve computing and networking, with custom AI accelerators now accounting for the bulk of the business. It is primarily a fabless designer, but holds some manufacturing in-house, such as for its best-of-breed film bulk acoustic resonator filters that sell into the Apple iPhone. In software, it sells virtualization, infrastructure, and security software to large enterprises, financial institutions, and governments. Broadcom is the product of consolidation. Its businesses are an amalgamation of former companies like legacy Broadcom and Avago Technologies in chips, as well as VMware, Brocade, CA Technologies, and Symantec in software.

    Rating
    Price Target
  • ASML Earnings: While the New 2026 Outlook Is No Big Surprise, Long-Term Prospects Vastly Improved

    ASML is the leader in lithography systems for manufacturing semiconductors with 90% market share. Lithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. Lithography allows chipmakers to increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML’s largest clients are TSMC, Samsung, Intel, SK Hynix, and Micron.

    Rating
    Price Target

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: